Shenzhen Hepalink Pharmaceutical Group Co., Ltd researches, produces and sells heparin pharmaceuticals products. The Company's products include heparin sodium active pharmaceutical ingredient.

Shenzhen HepaLink Pharmaceutical (H) (9989 HK)

Articles Of Association

Announcements and Notices - [List of Directors and their Role and Function]

List Of Directors And Their Roles And Functions

Announcements and Notices - [Results of EGM/SGM / Amendment of Constitutional Documents / Re-election or Appointment of Director subject to Shareholders' Approval / Other - Corporate Governance Related Matters]

Poll Results Of The 2025 First Extraordinary General Meeting Held On December 16, 2025

For The 2025 First Extraordinary General Meeting To Be Held On Tuesday, December 16, 2025

Announcements and Notices - [Notice of EGM/SGM / Closure of Books or Change of Book Closure Period]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Articles Of Association

List Of Directors And Their Roles And Functions

Poll Results Of The 2025 First Extraordinary General Meeting Held On December 16, 2025

For The 2025 First Extraordinary General Meeting To Be Held On Tuesday, December 16, 2025

Notice Of The 2025 First Extraordinary General Meeting